コーパス検索結果 (right1)
通し番号をクリックするとPubMedの該当ページを表示します
1 The number of patients with
one or more serious adverse event was similar across groups (
2 ; 22 patients (15%) on LCZ696 and 30 (20%) on valsartan had
one or more serious adverse event.
3 578 (19.7%) participants had
one or more serious adverse event; the frequency of serious a
4 One or more serious adverse events were reported for 214 (43%
5 ifampicin group and 12 (24%) of 50 in the placebo group had
one or more serious adverse events; none was thought to be re
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。